ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
35 hedge funds and large institutions have $2.74M invested in Oncternal Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
76% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 17
Holders
35
Holding in Top 10
–
Calls
$73K
Puts
$18K
Top Buyers
| 1 | +$282K | |
| 2 | +$280K | |
| 3 | +$41K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.5K |
| 5 |
Two Sigma Advisers
New York
|
+$9.24K |
Top Sellers
| 1 | -$381K | |
| 2 | -$207K | |
| 3 | -$102K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$87.7K |
| 5 |
VF
Virtu Financial
New York
|
-$66K |